This is a Validated Antibody Database (VAD) review about rat Plcg2, based on 7 published articles (read how Labome selects the articles), using Plcg2 antibody in all methods. It is aimed to help Labome visitors find the most suited Plcg2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (B-10) |
| Santa Cruz Biotechnology Plcg2 antibody (Santa Cruz Biotechnology, sc-5283) was used in western blot on human samples (fig 4a). Atherosclerosis (2019) ncbi |
mouse monoclonal (B-10) |
| Santa Cruz Biotechnology Plcg2 antibody (SantaCruz, sc-5283) was used in western blot on human samples (fig 3a). Sci Rep (2016) ncbi |
mouse monoclonal (B-10) |
| Santa Cruz Biotechnology Plcg2 antibody (Santa Cruz Biotechnology, sc-5283) was used in western blot on mouse samples . Molecules (2014) ncbi |
Cell Signaling Technology
domestic rabbit polyclonal |
| Cell Signaling Technology Plcg2 antibody (Cell Signaling, 3872) was used in western blot on mouse samples (fig s4). Bone Res (2020) ncbi |
domestic rabbit polyclonal |
| Cell Signaling Technology Plcg2 antibody (cell signalling, 3871P) was used in western blot on rat samples at 1:500 (fig 3d). Sci Rep (2017) ncbi |
domestic rabbit polyclonal |
| In order to investigate whether hepatitis C virus has a genetically determined lymphotropism through a co-receptor specific for the infection by lymphotropic hepatitis C virus, Cell Signaling Technology Plcg2 antibody (Cell Signaling, 3871) was used in western blot on human samples at 1:2000 (fig s9b). Nat Commun (2017) ncbi |
domestic rabbit polyclonal |
| Cell Signaling Technology Plcg2 antibody (Cell Signaling, 3872) was used in western blot on mouse samples (fig s4c). J Immunol (2016) ncbi |
domestic rabbit polyclonal |
| Cell Signaling Technology Plcg2 antibody (Cell Signaling, 3871) was used in western blot on mouse samples (fig s4c). J Immunol (2016) ncbi |
Articles Reviewed
- Barrachina M, Sueiro A, Izquierdo I, Hermida Nogueira L, Guitián E, Casanueva F, et al. GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity. Atherosclerosis. 2019;281:62-70 pubmed publisher
- Vélez P, Ocaranza Sánchez R, López Otero D, Grigorian Shamagian L, Rosa I, Guitián E, et al. Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches. Sci Rep. 2016;6:39603 pubmed publisher
- Baek J, Kim J, Cheon Y, Park S, Ahn S, Yoon K, et al. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone. Molecules. 2014;19:11628-44 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments